We recently published a list of 12 Best Defensive Stocks To Buy Right Now. In this article, we are going to take a look at ...

We recently compiled a list of the 10 Most Promising Dividend Stocks According to Hedge Funds. In this article, we are going ...

Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

To give some idea of the sheer size of Johnson & Johnson, a glance at its reported sales figure is revealing. In the fourth ...

New Brunswick, New Jersey-based Johnson & Johnson (JNJ) researches, develops, manufactures, and sells various products in the ...

The company forecast flat to 2% growth in 2025 per share adjusted profit, compared with $1.14 it earned in 2024. Analysts ...

UPS and JNJ present strong dividends and attractive valuations. See why these durable companies are great for a buy-and-hold ...

Some might describe Johnson & Johnson's business as boring, but sometimes, that's not such a bad thing. Selling pharmaceutical products is a steady and reliable business even when the economy is ...

I learned that Johnson & Johnson was very attached to our consumer identity, because our employees and external stakeholders were very attached to the consumer products that they all have used.

Johnson & Johnson (NYSE: JNJ ... clunky combination of classic pharmaceutical company and consumer healthcare products purveyor. That ended when it hived off the latter business as the separately ...

Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15.